While Merck's COVID pill molnupiravir is poised for authorization, efficacy could hamper use
29 November 2021 - 7:48PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
Von Apr 2023 bis Apr 2024